Epidermal growth factor receptor (EGFr) expression in non-small cell lung carcinomas correlates with metastatic involvement of hilar and mediastinal lymph nodes in the squamous subtype-Reference-Cited by-同舟云学术

Epidermal growth factor receptor (EGFr) expression in non-small cell lung carcinomas correlates with metastatic involvement of hilar and mediastinal lymph nodes in the squamous subtype

Published:1995-01 Issue:2 Volume:31 Page:178-183
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Fontanini G.,Vignati S.,Bigini D.,Mussi A.,Lucchi H.,Angeletti C.A.,Pingitore R.,Pepe S.,Basolo F.,Bevilacqua G.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference39 articles.

1. The new international staging system for lung cancer;Mountain;Surg Clin North Am,1987

2. Epidermal growth factor receptor status of histological sub-types of breast cancer;Sainsbury;Br J Cancer,1988

3. Expression of epidermal growth factor receptor (EGF-r) in non-small cell lung cancer. Use of archival tissue and correlation of EGF-r with histology, tumor size, node status and survival;Dazzi;Br J Cancer,1989

4. Expression of epidermal growth factor receptor in human gastric and colonic carcinomas;Yasui;Cancer Res,1988

5. Interleukin-4 receptor and epidermal growth factor receptor expression in colorectal cancer;Kaklamanis;Br J Cancer,1992

Cited by 110 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revamping precision treatment with nanoparticles envisaging effective drug delivery systems for ovarian cancer;Process Biochemistry;2024-03

2. New Predictive Biomarkers for Ovarian Cancer;Diagnostics;2021-03-07

3. A phase 1b study of necitumumab in combination with abemaciclib in patients with stage IV non-small cell lung cancer;Lung Cancer;2019-11

4. Cigarette smoke enhances oncogene addiction to c‐ MET and desensitizes EGFR ‐expressing non‐small cell lung cancer to EGFR TKI s;Molecular Oncology;2018-04-14

5. Correlation of EGFR-expression with safety and efficacy outcomes in SQUIRE: a randomized, multicenter, open-label, phase III study of gemcitabine–cisplatin plus necitumumab versus gemcitabine–cisplatin alone in the first-line treatment of patients with stage IV squamous non-small-cell lung cancer;Annals of Oncology;2016-08